Press Release: Samsung Biologics : Samsung Biologics reports first quarter 2025 financial results
Recorded Q1'25 consolidated revenue of KRW 1.3 trillionRecorded Q1'25 consolidated operating profit of KRW 486.7 billionCompany expected to maintain steady growth momentum in 2025 driven by enhanced operational...
Read full article »
Samsung Biologics is a manufacturer and distributor of biological products and provides laboratory testing services for the healthcare industry.
Read more